Natural language processing for patient selection in phase I or II oncology clinical trials

J Delorme, V Charvet, M Wartelle, F Lion… - JCO Clinical Cancer …, 2021 - ascopubs.org
PURPOSE Early discontinuation affects more than one third of patients enrolled in early-phase
oncology clinical trials. Early discontinuation is deleterious both for the patient and for the …

Using AI to automatically process data from unstructured health records of patients with lung cancer

M Aldea, P Rolland, S Simon, A Poplu, M Wartelle… - Cancer Research, 2024 - AACR
Introduction: Structured databases created from electronic health records (EHR) are crucial
for cancer research. Manual data entry into databases is both labor-intensive and error-prone…

Pan-tumor prognostic value of multiple immune protein expressions.

…, M Kerisit, S Champiat, M Wartelle… - 2019 - ascopubs.org
2618 Background: Using multiple immune-checkpoint proteins (ICP) screening in clinical
routine could improve the evaluation of patients’ prognosis and ultimately tailor their treatment …

Implications of learning effects for hospital costs of new health technologies: the case of intensity modulated radiation therapy

J Bonastre, E Noël, J Chevalier, JP Gerard… - International journal of …, 2007 - cambridge.org
… We are grateful to Muriel Ducourtieux and Muriel Wartelle for study data management
and to Marc Le Vaillant for his helpful contribution to modeling. We thank Pr. F. …

Psoriasis, alcohol, and liver disease.

JC Chaput, T Poynard, S Naveau, D Penso… - … (Clinical research ed …, 1985 - ncbi.nlm.nih.gov
… We are grateful for the contribution of Professor Robert Flamant, Muriel Wartelle, Pascale
Jan, and the departement de statistique medicale of Institut Gustave Roussy (Villejuif, France) …

Hyperosmolar non-ketotic diabetes mellitus associated with metolazone.

PA Rowe, HG Mather - British Medical Journal (Clinical research ed …, 1985 - ncbi.nlm.nih.gov
… We are grateful for the contribution of Professor Robert Flamant, Muriel Wartelle, Pascale
Jan, and the departement de statistique medicale of Institut Gustave Roussy (Villejuif, France) …

High-dose chemotherapy and blood autologous stem-cell rescue compared with standard chemotherapy in localized high-risk Ewing sarcoma: results of Euro-EWING …

J Whelan, MC Le Deley, U Dirksen… - Journal of Clinical …, 2018 - ascopubs.org
Purpose For over 30 years, the place of consolidation high-dose chemotherapy in Ewing
sarcoma (ES) has been controversial. A randomized study was conducted to determine …

[HTML][HTML] Strategies of radioiodine ablation in patients with low-risk thyroid cancer

M Schlumberger, B Catargi, I Borget… - … England Journal of …, 2012 - Mass Medical Soc
Background It is not clear whether the administration of radioiodine provides any benefit to
patients with low-risk thyroid cancer after a complete surgical resection. The administration of …

[HTML][HTML] Thyroidectomy without radioiodine in patients with low-risk thyroid cancer

S Leboulleux, C Bournaud, CN Chougnet… - … England Journal of …, 2022 - Mass Medical Soc
Background In patients with low-risk differentiated thyroid cancer undergoing thyroidectomy,
the postoperative administration of radioiodine (iodine-131) is controversial in the absence …

Successive osteosarcoma relapses after the first line O2006/Sarcome-09 trial: what can we learn for further phase-ii trials?

E Thebault, S Piperno-Neumann, D Tran… - Cancers, 2021 - mdpi.com
Simple Summary Osteosarcoma is the most common primary malignant bone tumour in
adolescents and young adults. The survival of osteosarcoma patients has not improved for four …